119-SRES-751 Journalist Public Summary

Public Summary

Headline Summary — A Senate simple resolution would name May 2026 “ALS Awareness Month” to raise visibility for the disease and those affected; it is symbolic and does not change law. [1]U.S. Senate — Legislation | United States Senate Committee on the Judiciary

What It Does — Formally recognizes May 2026 as ALS Awareness Month and signals the Senate’s support for people living with ALS and their caregivers. As a simple resolution, it expresses the chamber’s position and does not create programs, spend money, or go to the President. [1]U.S. Senate — Legislation | United States Senate Committee on the Judiciary

• ALS advocacy community: Groups use May to mobilize public attention and push for research and access to care (for example, campaigns from the Muscular Dystrophy Association and I AM ALS). [2]MDA — Muscular Dystrophy Association marks ALS Awareness Month (press release)
• Public‑health and research voices: CDC and NIH/NINDS materials highlight ALS’s severity and short average survival, reinforcing the case for awareness. [3]CDC — About Amyotrophic Lateral Sclerosis (ALS) | National ALS Registry
• Recent Senate practice: Similar ALS‑month resolutions have drawn bipartisan support and cleared the Senate by unanimous consent (e.g., the May 2025 ALS Awareness Month resolution). [4]Congress.gov — All Info - S.Res.266 (119th): May 2025 ALS Awareness Month

• No organized opposition has been evident; typical critiques of such measures are that they are purely symbolic and do not change policy or funding. [5]U.S. Senate — U.S. Senate Glossary — Simple resolution

What’s Next — As of May 29, 2026, S.Res. 751 is listed by the Senate Judiciary Committee with last recorded action on May 21, 2026. Because it is a simple resolution, only the Senate needs to act (often by unanimous consent); if adopted, it will not proceed to the House or the President. [1]U.S. Senate — Legislation | United States Senate Committee on the Judiciary

Why It Matters — ALS is a progressive, fatal neurodegenerative disease; most people live only 2–5 years after symptoms begin, and roughly 30,000–35,000 people in the U.S. are living with ALS at any time. An awareness month can amplify education, caregiver support, and research engagement. [3]CDC — About Amyotrophic Lateral Sclerosis (ALS) | National ALS Registry